Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 4, 2016
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceIra Jacobs, Danielle Petersel, Lesley G Shane, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 23, 2002
Nerve growth factor-induced differentiation changes the cellular organization of regulated Peptide release by PC12 cellsYuen-Keng Ng, Xinghua Lu, Simon C Watkins, et al.The Journal of Urology|August 20, 2008
Sonic Hedgehog mediator Gli2 regulates bladder mesenchymal patterningWei Cheng, Chung-Kwong Yeung, Yuen-Keng Ng, et al.Plos One|August 15, 2014
Transcriptional regulation of the tumor suppressor FHL2 by p53 in human kidney and liver cellsJiaying Xu, Junwei Zhou, Man-Shan Li, et al.Drug Discovery Today|April 28, 2015
Key considerations in the preclinical development of biosimilarsLynne A Bui, Susan Hurst, Gregory L Finch, et al.Gene|May 5, 2011
Characterization of human FHL2 transcript variants and gene expression regulation in hepatocellular carcinomaChor-Fung Ng, Wayne Jun-Wei Zhou, Patrick Kwok-Shing Ng, et al.Melanoma Research|April 9, 2014
Pan-erbB inhibition potentiates BRAF inhibitors for melanoma treatmentYuen-Keng Ng, Jia-Ying Lee, Kathryn M Supko, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 9, 2014
Comparative nonclinical assessments of the proposed biosimilar PF-05280014 and trastuzumab (Herceptin(®))Susan Hurst, Anne M Ryan, Chee-Keng Ng, et al.FEBS Letters|January 26, 2013
Full-length Mst1 exhibits growth promoting function in human hepatocellular carcinoma cellsYuen-Keng Ng, Wing-Sze Lau, Vivian Wai Yan Lui, et al.Journal of Pharmaceutical Sciences|May 21, 2014
Development and application of a robust N-glycan profiling method for heightened characterization of monoclonal antibodies and related glycoproteinsTanya Q Shang, Andrew Saati, Kelly N Toler, et al.Pageof 3